コンパニオンアニマル用医薬品市場：製品タイプ別、適応症別、動物タイプ別、流通チャネル別-2025-2030年世界予測

コンパニオンアニマル用医薬品市場は、2023年に143億9,000万米ドルと評価され、2024年には152億8,000万米ドルに達すると予測され、CAGR 6.67％で成長し、2030年には226億2,000万米ドルに達すると予測されています。

コンパニオンアニマル用医薬品市場には、犬、猫、その他の家畜を含むペット専用に設計された医薬品や薬剤が含まれ、疼痛管理、ワクチン接種、抗感染症薬、ワクチン、寄生虫駆除薬、皮膚科治療などの医療ニーズに対応しています。この分野は、ペットを家族の一員とみなすヒューマニゼーションの動向や、動物の健康やウェルネスへの関心に後押しされ、ペットの飼育が世界的に増加するにつれ、ますます重要性を増しています。需要は、獣医学の進歩、ペットヘルスケアに対する意識の高まり、ペット関連サービスへの支出能力の増加によって推進されています。アクセス可能な市場は、動物病院、家庭用薬局、オンライン販売プラットフォームに広がっています。主な成長要因としては、ペットの飼育率の増加、急増する獣医インフラ、薬剤製剤の技術進歩、ペットの慢性疾患の急増などが挙げられます。注射に代わる経口薬の開発、個々の動物に合わせた個別化医療、ペットの飼育率が上昇している新興国市場での成長機会などがあります。しかし、医薬品価格の高騰、医薬品認可のための厳しい規制要件、採用の妨げとなりうる医薬品の潜在的副作用などの障害に直面しています。景気減速はペットヘルスケアへの支出に影響し、市場拡大にさらなる課題をもたらします。イノベーションは、環境にやさしく、安全で費用対効果の高い医薬品の開発や、バイオテクノロジーを活用した新規治療薬の開発を軸とすることができます。製薬会社と動物病院との共同研究が、治療の有効性と安全性において画期的な進歩をもたらすかもしれないです。医薬品を補完する治療用栄養剤やウェルネス製品への動向も、市場開拓の原動力となると思われます。市場は競争的でダイナミックであり、急速な技術進歩や飼い主の嗜好の変化を特徴としているため、リアルタイムの市場分析と人口動態の変化や消費者ニーズの進化に対応する適応戦略が必要となります。技術革新と消費者の需要を結びつけることに成功した企業は、大きな市場シェアを獲得する態勢を整えています。

市場力学：急速に進化するコンパニオンアニマル用医薬品市場の主要市場インサイトを公開

コンパニオンアニマル用医薬品市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 人獣共通感染症および慢性疾患の有病率の増加
  • コンパニオンアニマルの増加と衛生に対する意識
  • 動物ヘルスケアに関する人々の意識と支出の増加
• 市場抑制要因
  • コンパニオンアニマルヘルスAPIに関連するいくつかのリスク要因
• 市場機会
  • コンパニオンアニマル用の新薬とワクチンの開発
  • 新興経済諸国における市場プレイヤーの出現と戦略的提携
• 市場の課題
  • 医薬品の承認に関連する厳しい規制

ポーターの5つの力：コンパニオンアニマル用医薬品市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：コンパニオンアニマル用医薬品市場における外部からの影響の把握

外部マクロ環境要因は、コンパニオンアニマル用医薬品市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析コンパニオンアニマル用医薬品市場における競合情勢の把握

コンパニオンアニマル用医薬品市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスコンパニオンアニマル用医薬品市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、コンパニオンアニマル用医薬品市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 人獣共通感染症および慢性疾患の蔓延の増加
    • ペットの数の増加と衛生に関する意識
    • 動物のヘルスケアに関する人々の意識と支出の増加
  • 抑制要因
    • ペット動物用医薬品 APIに関連するいくつかのリスク要因
  • 機会
    • ペット用新薬・ワクチンの開発
    • 新興経済諸国における市場プレーヤーの出現と戦略的連携
  • 課題
    • 医薬品の承認に関する厳格な規制
• 市場セグメンテーション分析
  • 製品：ペットの一般的な痛みや慢性的な痛みを治療するための多様な鎮痛剤
  • 適応症：ペットの抗菌薬耐性および感染症に対する先進的な医薬品の開発への注目が高まる
  • 動物の種類：ペットとしての犬の導入が増加し、その治療費も増加している
  • 配信チャネル：オンラインチャネルを通じてコンパニオンアニマル用医薬品を入手する際のアクセス性と利便性の向上
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 コンパニオンアニマル用医薬品市場：製品別

• 鎮痛剤
• 抗感染薬
• 抗炎症
• 医薬品添加飼料添加物
• 寄生虫駆除剤
• ワクチン

第7章 コンパニオンアニマル用医薬品市場適応症別

• 行動障害
• 皮膚疾患
• 感染症
• 整形外科疾患
• 痛み

第8章 コンパニオンアニマル用医薬品市場動物の種類別

• 猫
• 犬
• 馬

第9章 コンパニオンアニマル用医薬品市場：流通チャネル別

• オンライン薬局
• 小売薬局
• 獣医クリニック
• 動物病院

第10章 南北アメリカのコンパニオンアニマル用医薬品市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のコンパニオンアニマル用医薬品市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのコンパニオンアニマル用医薬品市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ベーリンガーインゲルハイム、犬を総合的に寄生虫から守る新しいチュアブルソリューション「NexGard SPECTRA」をインドで発売
  • ゾエティス、画期的な犬の変形性関節症およびアレルギー治療薬でFDAの承認を取得
  • アクストン・バイオサイエンスはペットの健康に重点を移し、最先端の技術を使って新しい治療法を開発
  • ゾエティス、ジュロックス買収により世界展開を拡大、ペットおよび家畜ケア向け獣医薬ポートフォリオを強化

企業一覧

• Phibro Animal Health Corporation
• Hipra Laboratories, S.A.
• Vetneeds Group
• Neogen Corporation
• Norbrook Laboratories Ltd.
• Tianjin Ringpu Biotechnology Co., Ltd.
• Stanex Drugs and Chemicals Pvt Ltd.
• Indian Immunologicals Ltd.
• Alivira Animal Health Limited
• Kyoritsu Seiyaku Corporation
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• SkyEc Pharmaceuticals Private Limited
• Endovac Animal Health, LLC
• Lutim Pharma Pvt. Ltd.
• Virbac S.A.
• Ceva Sante Animale
• Meiji Group
• Boehringer Ingelheim International GmbH
• Century Pharmaceuticals Ltd.
• Zydus Animal Health
• Vetbiolix
• Merck & Co. Inc.
• Veko Care
• Ashish Life Science Pvt. Ltd.
• Chanelle Pharma
• Zoetis Inc.
• Hester Biosciences Limited
• Orion Corporation
• Eco Animal Health Group PLC

LIST OF FIGURES

• FIGURE 1. COMPANION ANIMAL PHARMACEUTICALS MARKET RESEARCH PROCESS
• FIGURE 2. COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. COMPANION ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. COMPANION ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COMPANION ANIMAL PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COMPANION ANIMAL PHARMACEUTICALS MARKET DYNAMICS
• TABLE 7. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY MEDICATED FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PARASITICIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY BEHAVIORAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DERMATOLOGIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ORTHOPEDIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PAIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY CATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DOGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY HORSES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 45. CANADA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 60. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 66. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. CHINA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. INDIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 76. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 84. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 88. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 100. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 104. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 113. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 125. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 137. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 139. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 140. ITALY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 149. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 154. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 155. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 156. POLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 159. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 160. QATAR COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 161. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 165. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 169. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 173. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 177. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 181. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 185. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 189. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 193. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM COMPANION ANIMAL PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 197. COMPANION ANIMAL PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 198. COMPANION ANIMAL PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

The Companion Animal Pharmaceuticals Market was valued at USD 14.39 billion in 2023, expected to reach USD 15.28 billion in 2024, and is projected to grow at a CAGR of 6.67%, to USD 22.62 billion by 2030.

The companion animal pharmaceuticals market encompasses drugs and medications designed specifically for pets, including dogs, cats, and other domesticated animals, addressing medical needs such as pain management, vaccination, anti-infectives, vaccines, parasiticides, and dermatological treatments. This sector is increasingly vital as pet ownership rises globally, driven by humanization trends where pets are viewed as family members, alongside concerns for animal health and wellness. Demand is propelled by advancing veterinary medicine, growing awareness of pet healthcare, and increased spending capability on pet-related services. The accessible market extends across veterinary clinics, home pharmacies, and online sales platforms. Key growth influencers include the increase in pet adoption rates, burgeoning veterinary infrastructure, technological advancements in drug formulations, and proliferation of chronic pet diseases. Opportunities arise from developing oral alternatives to injections, personalized medicine tailored to individual animals, and growth in emerging markets with rising pet adoption rates. However, market growth faces obstacles such as high cost of pharmaceuticals, stringent regulatory requirements for drug approval, and potential side effects of medications that could deter adoption. Economic slowdown impacts spending on pet healthcare, further challenging market expansion. Innovation can pivot around the development of eco-friendly, safe, and cost-effective medications, and leveraging biotechnology for novel therapeutics. Collaborative research between pharmaceuticals and veterinary institutions might offer breakthroughs in treatment efficacy and safety. Trending interest in therapeutic nutrition and wellness products supplementary to pharmaceuticals can also drive market exploration. The market is competitive and dynamic, characterized by rapid technological advancements and shifts in pet owner preferences, necessitating real-time market analysis and adaptive strategies to address demographic changes and evolving consumer needs. Companies successful in marrying innovation with consumer demand are poised to capture significant market share.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Companion Animal Pharmaceuticals Market

The Companion Animal Pharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Prevalence of Zoonotic and Chronic Diseases
  • Rising Number of Companion Animals and Awareness About their Hygiene
  • Increasing Awareness and Expenditure Among People Regarding Animal Healthcare
• Market Restraints
  • Several Risk Factors Associated with Companion Animal Health APIs
• Market Opportunities
  • Development of New Drugs and Vaccines for Companion Animal
  • Strategic Collaborations Along with Emergence of Market Players Across the Developing Economies
• Market Challenges
  • Stringent Regulations Associated with the Approval for Drugs

Porter's Five Forces: A Strategic Tool for Navigating the Companion Animal Pharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Companion Animal Pharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Companion Animal Pharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Companion Animal Pharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Companion Animal Pharmaceuticals Market

A detailed market share analysis in the Companion Animal Pharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Companion Animal Pharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Companion Animal Pharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Companion Animal Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include Phibro Animal Health Corporation, Hipra Laboratories, S.A., Vetneeds Group, Neogen Corporation, Norbrook Laboratories Ltd., Tianjin Ringpu Biotechnology Co., Ltd., Stanex Drugs and Chemicals Pvt Ltd., Indian Immunologicals Ltd., Alivira Animal Health Limited, Kyoritsu Seiyaku Corporation, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, SkyEc Pharmaceuticals Private Limited, Endovac Animal Health, LLC, Lutim Pharma Pvt. Ltd., Virbac S.A., Ceva Sante Animale, Meiji Group, Boehringer Ingelheim International GmbH, Century Pharmaceuticals Ltd., Zydus Animal Health, Vetbiolix, Merck & Co. Inc., Veko Care, Ashish Life Science Pvt. Ltd., Chanelle Pharma, Zoetis Inc., Hester Biosciences Limited, Orion Corporation, and Eco Animal Health Group PLC.

Market Segmentation & Coverage

This research report categorizes the Companion Animal Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Analgesics, Anti-infectives, Anti-inflammatory, Medicated Feed Additives, Parasiticides, and Vaccines.
• Based on Indication, market is studied across Behavioral Disorders, Dermatologic Diseases, Infectious Diseases, Orthopedic Diseases, and Pain.
• Based on Animal Type, market is studied across Cats, Dogs, and Horses.
• Based on Distribution Channel, market is studied across Online Pharmacies, Retail Pharmacies, Veterinary Clinics, and Veterinary Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Prevalence of Zoonotic and Chronic Diseases
    • 5.1.1.2. Rising Number of Companion Animals and Awareness About their Hygiene
    • 5.1.1.3. Increasing Awareness and Expenditure Among People Regarding Animal Healthcare
  • 5.1.2. Restraints
    • 5.1.2.1. Several Risk Factors Associated with Companion Animal Health APIs
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of New Drugs and Vaccines for Companion Animal
    • 5.1.3.2. Strategic Collaborations Along with Emergence of Market Players Across the Developing Economies
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent Regulations Associated with the Approval for Drugs
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Diverse range of analgesics to treat general and chronic pain in companion animals
  • 5.2.2. Indication: Rising focus on developing advanced pharmaceuticals for antimicrobial resistance and infectious diseases in companion animals
  • 5.2.3. Animal Type: Increased adoption of dogs as companion animals and rising expenditure on their treatments
  • 5.2.4. Distribution Channel: Enhanced accessibility and convenience of attaining companion animal pharmaceuticals through online channels
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Companion Animal Pharmaceuticals Market, by Product

• 6.1. Introduction
• 6.2. Analgesics
• 6.3. Anti-infectives
• 6.4. Anti-inflammatory
• 6.5. Medicated Feed Additives
• 6.6. Parasiticides
• 6.7. Vaccines

7. Companion Animal Pharmaceuticals Market, by Indication

• 7.1. Introduction
• 7.2. Behavioral Disorders
• 7.3. Dermatologic Diseases
• 7.4. Infectious Diseases
• 7.5. Orthopedic Diseases
• 7.6. Pain

8. Companion Animal Pharmaceuticals Market, by Animal Type

• 8.1. Introduction
• 8.2. Cats
• 8.3. Dogs
• 8.4. Horses

9. Companion Animal Pharmaceuticals Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Online Pharmacies
• 9.3. Retail Pharmacies
• 9.4. Veterinary Clinics
• 9.5. Veterinary Hospitals

10. Americas Companion Animal Pharmaceuticals Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Companion Animal Pharmaceuticals Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Companion Animal Pharmaceuticals Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Boehringer Ingelheim Introduces NexGard SPECTRA in India, a New Chewable Solution for Comprehensive Dog Parasite Protection
  • 13.3.2. Zoetis Receives FDA Approval for Groundbreaking Canine Osteoarthritis and Allergy Treatments
  • 13.3.3. Akston Biosciences Shifts Focus to Pet Health, Using Cutting-Edge Technology to Develop New Treatments
  • 13.3.4. Zoetis Expands Global Reach with Acquisition of Jurox, Enhancing Veterinary Medication Portfolio for Companion and Livestock Care

Companies Mentioned

• 1. Phibro Animal Health Corporation
• 2. Hipra Laboratories, S.A.
• 3. Vetneeds Group
• 4. Neogen Corporation
• 5. Norbrook Laboratories Ltd.
• 6. Tianjin Ringpu Biotechnology Co., Ltd.
• 7. Stanex Drugs and Chemicals Pvt Ltd.
• 8. Indian Immunologicals Ltd.
• 9. Alivira Animal Health Limited
• 10. Kyoritsu Seiyaku Corporation
• 11. Dechra Pharmaceuticals PLC
• 12. Elanco Animal Health Incorporated
• 13. SkyEc Pharmaceuticals Private Limited
• 14. Endovac Animal Health, LLC
• 15. Lutim Pharma Pvt. Ltd.
• 16. Virbac S.A.
• 17. Ceva Sante Animale
• 18. Meiji Group
• 19. Boehringer Ingelheim International GmbH
• 20. Century Pharmaceuticals Ltd.
• 21. Zydus Animal Health
• 22. Vetbiolix
• 23. Merck & Co. Inc.
• 24. Veko Care
• 25. Ashish Life Science Pvt. Ltd.
• 26. Chanelle Pharma
• 27. Zoetis Inc.
• 28. Hester Biosciences Limited
• 29. Orion Corporation
• 30. Eco Animal Health Group PLC